Adult studies
Reduction in serum IgE and improvements in selected clinical and laboratory parameters.
The original shloka
च्यवनप्राशं परमममृत्यं ऋषिभिर्विहितं पुरा। रसायनं श्रेष्ठतमं सर्वरोगहरं परम्॥
Chyawanprash is the supreme nectar created in ancient times by the Rishis. It is the foremost among Rasayanas and the ultimate destroyer of diseases.
CHARAKA SAMHITA · CHIKITSA STHANA 1.1.62–74
The story of Chyawanprash is the story of Ayurveda itself – a science of life, longevity and balance. Conceived by Rishi Chyawan and documented in the Charaka Samhita as the ultimate Rasayana, its purpose was never just to cure, but to build – to build ojas, immunity and resilience.
This book traces how Dabur, the world’s first and largest Chyawanprash maker, honoured that legacy, reinvented it for the contemporary world, and established it as one of India’s most clinically studied and loved Ayurvedic health supplements.
Introduction
Dabur Chyawanprash: From Classical Rasayana Wisdom to Evidence-Based Wellness
Dabur Chyawanprash (DCP) represents a distinctive convergence of classical Ayurvedic wisdom, formulation science, modern biomedical research, and human clinical evidence.
This evidence review, developed by Dabur Research Foundation (DRF) with valuable inputs from DRDC, brings together the available traditional, mechanistic, preclinical, clinical, and safety evidence into a unified scientific framework.
At its core, Chyawanprash is a classical Rasayana formulation associated with vitality, resilience, nourishment, healthy ageing and the body’s natural resistance to disease. The contemporary scientific evidence compiled in this review provides a compelling biological and translational framework for these traditional concepts.
The scientific story
Seven stages · one continuum- 01Classical Rasayana
- 02Multicomponent formulation
- 03Biological mechanisms
- 04Cellular resilience
- 05Preclinical validation
- 06Human clinical outcomes
- 07Consumer-relevant wellness benefits
This convergence is the central strength of the DCP evidence platform.
Integrated evidence continuum illustrating the progression from classical Rasayana principles and multicomponent formulation through biological mechanisms, cellular resilience, preclinical and clinical evidence, to consumer-relevant wellness outcomes.
DRF Scientific Validation Framework
Althea DRF Life SciencesA distinguishing feature of this evidence review is the systematic scientific validation strategy employed by Althea DRF Life Sciences to evaluate Dabur Chyawanprash using contemporary biomedical research methodologies. Beyond compiling available literature and evidence, DRF designed and executed a translational research programme intended to bridge traditional Ayurvedic concepts with modern biological mechanisms, preclinical outcomes, human evidence, and consumer-relevant health benefits.
The scientific programme was built around a structured evidence-generation framework comprising mechanistic investigations, efficacy studies, safety evaluations, translational analyses, and clinical evidence integration. Studies were conducted using validated cellular and animal models relevant to immunity, respiratory health, allergy, oxidative stress, cellular resilience, mitochondrial function, energy metabolism, healthy ageing, and general wellness. Where applicable, investigations were conducted within GLP-compliant scientific environments and internationally recognized laboratory infrastructures, including AAALAC-accredited animal research facilities that adhere to globally accepted standards of scientific quality, ethics, and animal welfare.
The overarching objective was to establish scientific continuity across the evidence hierarchy:Traditional Ayurvedic knowledge → Mechanistic biology → Preclinical efficacy → Clinical translation → Consumer benefit claims
This translational framework enabled biological hypotheses derived from classical Rasayana principles to be tested using contemporary scientific endpoints and subsequently linked to human clinical observations. Rather than relying on isolated experimental findings, DRF approach emphasized convergence of evidence across multiple experimental systems and populations, thereby strengthening the scientific credibility of the formulation’s health positioning.
Scientific Substantiation of 3X Immunity Action
Tap a circleOne of the most distinctive scientific propositions associated with DCP is its 3X Immunity Action, built around three complementary components of innate immune defence: dendritic-cell activation, natural killer-cell activity and macrophage function. This positioning is also reflected in Dabur’s public scientific communication.
The evidence demonstrates that DCP can modulate key components of innate immunity, providing a mechanistic framework for its immune-health positioning.
01
Dendritic Cell Activation
DCP demonstrated dose-dependent effects on dendritic-cell activation, including increases in key immune mediators such as TNF-α, IL-1β and MIP-1α.
Together, these findings provide a scientifically coherent basis for describing DCP as acting across three complementary arms of innate immune defence, rather than through a single immune pathway.
A Multidimensional Scientific Evidence Base
Cells · animals · humansThe scientific strength of DCP lies not in a single ingredient, pathway or biological endpoint, but in the convergence of multiple complementary mechanisms. Evidence generated across cellular systems, animal models and human studies demonstrates activity spanning:
- Innate immune defence and immune-cell function
- Respiratory and seasonal wellness
- Infection- and allergy-related health
- Antioxidant and cytoprotective responses
- Cellular energy and metabolic resilience
- Cellular maintenance and resilience
- General wellbeing and quality-of-life parameters
This multidimensional profile is particularly relevant to the traditional Rasayana concept, where health is viewed not simply as the absence of disease, but as the ability of the body to maintain physiological balance, withstand stress and sustain vitality.
The alignment between these mechanistic findings and the favorable immune-related outcomes observed in clinical studies provides a strong scientific rationale for the formulation’s immune-support positioning.
From Mechanism to Human Benefit
Mechanistic plausibilityThe most important strength of the evidence review is the translational continuity between mechanistic biology and human evidence.
Beyond immunity, the evidence review extends the scientific understanding of DCP into cellular resilience and physiological adaptation.
At the cellular level, DCP demonstrated effects associated with cellular resilience and protection, including approximately 74% cytoprotection in a human liver-cell oxidative-stress model and increased telomerase activity in human PBMCs, reaching 3.4-fold at the highest tested concentration. These findings support mechanistic interpretations around cellular protection, resilience and maintenance.
DCP demonstrated cytoprotective activity under oxidative stress, including restoration of cellular viability in lung epithelial cells.
Similarly, findings related to mitochondrial function suggest preservation of mitochondrial integrity and cellular energy homeostasis under cellular stress.
Together with the telomerase and cellular-senescence findings, these results expand the scientific narrative from immune defence alone toward cellular resilience, vitality and healthy physiological adaptation.
Importantly, the evidence review appropriately distinguishes these mechanistic findings from direct human clinical outcomes. Cellular studies establish biological plausibility; human clinical studies provide the stronger basis for consumer-level outcome positioning.
~74%
cytoprotection in a human liver-cell oxidative-stress model
Liver cells · HepG23.4-fold
telomerase activity in human PBMCs at the highest tested concentration
Human PBMCsClinical Evidence: A Consistent Pattern Across Health Dimensions
Human studiesThe human evidence assembled in this review demonstrates a broad and consistent pattern across immune, respiratory, allergy-related and wellbeing outcomes. The evidence base includes:
Seasonal-health studies
Reduction in IgE and ESR, improvements in selected respiratory-function parameters and reduction in plasma cortisol.
Pediatric randomized study
Fewer infection/allergy-related episodes, shorter illness duration, reduced absenteeism and improvements in selected quality-of-life and physical wellbeing measures.
Multicentre COVID-era study
Lower observed COVID-19 incidence and improved quality of life in the DCP group, while this evidence review appropriately cautions against interpreting hospitalization findings independently as proof of protection against severe COVID-19.
Swipe for more studies
This collective evidence supports the strongest clinical positioning of DCP around immune-health support, respiratory/seasonal wellness and general wellbeing.
A Strong Safety and Tolerability Foundation
Nonclinical and clinical2,000mg/kg
Acute exposure: no treatment-related toxicity was observed
1,000mg/kg/day
Reported NOAEL in both the 28-day and 90-day repeated-dose studies
0
Product-related serious adverse events identified
The safety database provides an additional pillar of confidence.
Nonclinical studies included acute, 28-day and 90-day repeated-dose oral toxicity investigations. No treatment-related toxicity was observed following acute exposure at 2,000 mg/kg, while the reported NOAEL was 1,000 mg/kg/day in both the 28-day and 90-day repeated-dose studies.
Clinical safety data across adult, pediatric and healthy populations were also generally favourable. In the 90-day comparative study, two events were considered possibly related to DCP, pruritus ani and mild skin allergy, and both were mild and resolved with symptomatic treatment; no product-related serious adverse event was identified.
Executive Conclusion
The significance of this evidence review is therefore not simply that DCP has been studied, it is that the evidence forms a connected scientific continuum from Ayurveda to mechanism, from mechanism to clinical observation, and from clinical evidence to a modern framework for wellness and resilience.
Dabur Chyawanprash represents a compelling example of evidence-based Ayurveda, where centuries-old Rasayana principles are supported by contemporary scientific investigation and translated into measurable biological and human health outcomes.
The totality of evidence demonstrates a broad, multidimensional scientific profile, with the strongest convergence around immune-health support, respiratory and seasonal wellness, infection/allergy-related health, cellular resilience and general wellbeing. The mechanistic evidence further strengthens this foundation by demonstrating modulation of innate immune functions, cytoprotective responses, cellular energy status and cellular maintenance.
The evidence assembled in this review positions Dabur Chyawanprash as more than a traditional Ayurvedic formulation. It represents a scientifically investigated, multidimensional wellness formulation in which traditional Rasayana principles can be connected to contemporary evidence across immune function, respiratory health, cellular protection, energy metabolism and physiological resilience.
Read the full conclusion
This comprehensive evidence platform reinforces Dabur’s leadership in advancing scientifically substantiated Ayurveda and provides a strong foundation for future scientific communication, claim substantiation, innovation, regulatory strategy and global positioning of Dabur Chyawanprash. Dabur itself describes its Chyawanprash research programme as part of its broader commitment to evidence-based Ayurveda.
Further, this evidence review highlights the value of a rigorous translational-research approach in validating traditional Ayurvedic formulations. Through systematic investigations conducted across validated cellular systems, animal models, safety studies, mechanistic biology and human clinical research, DRF has established a comprehensive evidence platform that connects Ayurvedic Rasayana concepts with measurable biological and clinical outcomes. The resulting body of evidence not only strengthens scientific confidence in Dabur Chyawanprash but also provides a robust foundation for regulatory evaluation, claim substantiation, healthcare-professional engagement, scientific communication, product innovation and global market expansion. Together with Dabur India’s longstanding commitment to research, quality and evidence-based Ayurveda, this work reinforces Dabur Chyawanprash as one of the most comprehensively studied and scientifically substantiated Ayurvedic wellness formulations available today.
Begin with
Open Heritage
Heritage, History and Ayurvedic Foundation
From traditional Rasayana to evidence-based science.